Table 1 Clinicopathological characteristics for patients 1-10 (PT1-PT10) and final RNA-seq samples

From: Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases

Patient Sample PT1 PT2 PT3 PT4 PT5 PT6 PT7 PT8 PT9 PT10
DAN   1 1 1 1 1 1 1 0 1 2
PAN   1 1 1 2 1 1 1 0 1 4
CAN   2 1 2 1 3 1 3 2 4 4
MET   1 1 1 3 1 1 1 0 0 0
LYMPH   0 1 0 1 0 0 0 0 0 0
Age at RP, years   61 51 67 49 63 64 69 65 52 68
Pre-operative PSA, ng/mL   21.0 28.9 18.1 47.1 5.6 22.6 155 7.0 20.6 7.2
Pathological Gleason Score   7 6 7 8 7 7 7 7 7 7
  CAN 1 4 + 3, 3 + 3 4 + 4, 4 + 3 3 + 3, 3 + 4 4 + 4, 3 + 4 3 + 4 + 5, 3 + 3,
  CAN 2 4 + 5   4 + 3   4 + 4,   3 + 3, 4 + 4 3 + 3, 3 + 3,
  CAN 3      4 + 5   4 + 4   3 + 4 + 5, 3 + 4,
Gleason gradesa           3 + 4 4 + 4
  MET 1 4 + 3   4 + 3 4 + 5 4 + 5 4 + 4 4 + 4    
  MET 2     4 + 5       
  MET 3          
pT   pT3 pT3 pT3 pT3 pT3 pT3 pT3 pT3 pT3 pT3
pN   pN1 pN1 pN1 pN1 pN1 pN1 pN1 pN1 pN1 pN1